Hematology TimesEC supports continued use of ponatinibJanuary 21, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesNHS cuts 5 blood cancer drugs from CDF, adds 1January 14, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated IssuesCMLNon-Hodgkin Lymphoma
Hematology TimesFinding could help docs tailor treatment for myeloid leukemiasDecember 9, 2014Leukemia, Myelodysplasia, TransplantationAMLCML
Hematology TimesDiscovery reveals potential approach to treat CMLNovember 20, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesCompounds could treat CML more effectivelyNovember 11, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology NewsVitiligo, alopecia more likely in GVHD when donor is female and recipient is maleSeptember 10, 2014Myelodysplastic SyndromeTransfusion MedicineCMLCellular Therapy
Hematology TimesStudy explains BCR-ABL-independent imatinib resistanceSeptember 4, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesToward better treatment of CMLAugust 22, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesSwitch to nilotinib improves deep molecular response in CMLJune 19, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology NewsImatinib appears safe, effective for the long haulJune 17, 2014Transfusion MedicineCML
The Journal of Community and Supportive OncologyMolecular monitoring and minimal residual disease in the management of chronic myelogenous leukemiaMay 27, 2014Leukemia, Myelodysplasia, TransplantationPatient & Survivor CareCML
Hematology TimesFDA approves CML drug for home administrationMay 6, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesCell adherence linked to treatment resistance in CMLMarch 14, 2014Leukemia, Myelodysplasia, TransplantationCML
